This study analyzed the anti-inflammatory effects of epigallocatechin gallate (ECGC). The study was conducted with human cells. After treatment with EGCG, the initial step in vascular inflammation (endothelial exocytosis) was measured in these cells. The resulting data indicated that ECGC decreased vascular inflammation by increasing nitric oxide (NO), a compound involved in blood vessel dilation. Further details can be found in the study.
Munekazu Yamakuchi, Clare Bao, Marcella Ferlito, Charles J Lowenstein